beta-lapachone has been researched along with Acute Disease in 2 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Acute Disease: Disease having a short and relatively severe course.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cascabulho, CM | 1 |
Meuser-Batista, M | 1 |
Moura, KCG | 1 |
Pinto, MDC | 1 |
Duque, TLA | 1 |
Demarque, KC | 1 |
Guimarães, ACR | 1 |
Manso, PPA | 1 |
Pelajo-Machado, M | 1 |
Oliveira, GM | 1 |
Castro, SL | 1 |
Menna-Barreto, RF | 1 |
Li, CJ | 1 |
Zhang, LJ | 1 |
Dezube, BJ | 1 |
Crumpacker, CS | 1 |
Pardee, AB | 1 |
2 other studies available for beta-lapachone and Acute Disease
Article | Year |
---|---|
Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Chagas Disease; Disease Models, Animal; Electrocar | 2020 |
Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.
Topics: Acute Disease; Antiviral Agents; Camptothecin; Cells, Cultured; Chronic Disease; Curcumin; Gene Expr | 1993 |